Matches in Nanopublications for { ?s ?p "[ERCC1 C8092A (rs3212986) polymorphism as a predictive marker in esophageal cancer patients treated with cisplatin/5-FU-based neoadjuvant therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP381446.RAAqIdUXzrttze6a4ElCTQDTXAuvOSY48AcA_HYFjV5k0130_assertion description "[ERCC1 C8092A (rs3212986) polymorphism as a predictive marker in esophageal cancer patients treated with cisplatin/5-FU-based neoadjuvant therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP381446.RAAqIdUXzrttze6a4ElCTQDTXAuvOSY48AcA_HYFjV5k0130_provenance.
- NP381333.RA6OA6Qxli0iepoXnQ_-ow1MML0yUyO0Egy6IgqNX80Zk130_assertion description "[ERCC1 C8092A (rs3212986) polymorphism as a predictive marker in esophageal cancer patients treated with cisplatin/5-FU-based neoadjuvant therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP381333.RA6OA6Qxli0iepoXnQ_-ow1MML0yUyO0Egy6IgqNX80Zk130_provenance.
- NP381553.RA7HJwt6g6nI4tl-imywfxCz_Sdke0ZJjbEowqj1Ag-3I130_assertion description "[ERCC1 C8092A (rs3212986) polymorphism as a predictive marker in esophageal cancer patients treated with cisplatin/5-FU-based neoadjuvant therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP381553.RA7HJwt6g6nI4tl-imywfxCz_Sdke0ZJjbEowqj1Ag-3I130_provenance.
- NP1103953.RACvGcwYXrthmlNwpOEAGhd35QWv_smAQ8GJgLg0MBdjI130_assertion description "[ERCC1 C8092A (rs3212986) polymorphism as a predictive marker in esophageal cancer patients treated with cisplatin/5-FU-based neoadjuvant therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1103953.RACvGcwYXrthmlNwpOEAGhd35QWv_smAQ8GJgLg0MBdjI130_provenance.
- assertion description "[ERCC1 C8092A (rs3212986) polymorphism as a predictive marker in esophageal cancer patients treated with cisplatin/5-FU-based neoadjuvant therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[ERCC1 C8092A (rs3212986) polymorphism as a predictive marker in esophageal cancer patients treated with cisplatin/5-FU-based neoadjuvant therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[ERCC1 C8092A (rs3212986) polymorphism as a predictive marker in esophageal cancer patients treated with cisplatin/5-FU-based neoadjuvant therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1103955.RA3yLx9fzCUfnriCU7J_Z7YkEmuy71wgM8It-lqPKZO_M130_assertion description "[ERCC1 C8092A (rs3212986) polymorphism as a predictive marker in esophageal cancer patients treated with cisplatin/5-FU-based neoadjuvant therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1103955.RA3yLx9fzCUfnriCU7J_Z7YkEmuy71wgM8It-lqPKZO_M130_provenance.
- NP1103954.RAGWWMgVbxolowNMDCFjHO7q43jbYM7SHJl4vCZoM9Xd4130_assertion description "[ERCC1 C8092A (rs3212986) polymorphism as a predictive marker in esophageal cancer patients treated with cisplatin/5-FU-based neoadjuvant therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1103954.RAGWWMgVbxolowNMDCFjHO7q43jbYM7SHJl4vCZoM9Xd4130_provenance.